United States set
language
Menu Shopping cart $0 Search
Advanced Search
You are here:   Home Scientific References

Scientific References

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

Filter references:
Find Product:

  • References to t-PA Human ELISA

    • Gurbuz Y, Ozturk B, Tutuncu EE, Sencan I, Cicek Senturk G, Altay FA. Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients. Jundishapur J Microbiol. 2015 Oct 20;8(10):e26514. doi: 10.5812/jjm.26514. eCollection 2015 Oct. PubMed PMID: 26587219. PubMed CentralPMCID: PMC4644349. See more on PubMed

  • References to Urine CartiLaps® ELISA (CTX-II)

    • Henrotin Y, Bannuru R, Malaise M, Ea HK, Confavreux C, Bentin J, Urbin-Choffray D, Conrozier T, Brasseur JP, Thomas P, Hick AC, Marinello A, Giordan N, Richette P. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study. BMC Musculoskelet Disord. 2019 Jun 18;20(1):293. doi: 10.1186/s12891-019-2667-0. PubMed PMID: 31215422. PubMed CentralPMCID: PMC6580647. See more on PubMed

  • References to Urine Pre-Clinical CartiLaps® ELISA (CTX-II)

    • Henrotin Y, Bannuru R, Malaise M, Ea HK, Confavreux C, Bentin J, Urbin-Choffray D, Conrozier T, Brasseur JP, Thomas P, Hick AC, Marinello A, Giordan N, Richette P. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study. BMC Musculoskelet Disord. 2019 Jun 18;20(1):293. doi: 10.1186/s12891-019-2667-0. PubMed PMID: 31215422. PubMed CentralPMCID: PMC6580647. See more on PubMed

  • References to Urocortin 2 Mouse ELISA

    • Chen A, Vaughan J, Vale WW. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. Mol Endocrinol. 2003 Aug;17(8):1622-39. doi: 10.1210/me.2003-0054. Epub 2003 May 22. PubMed PMID: 12764078. See more on PubMed
    • Chen A, Blount A, Vaughan J, Brar B, Vale W. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology. 2004 May;145(5):2445-57. doi: 10.1210/en.2003-1570. Epub 2004 Jan 21. PubMed PMID: 14736736. See more on PubMed
    • Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW, Peterson KL. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3697-702. doi: 10.1073/pnas.0307324101. Epub 2004 Feb 27. PubMed PMID: 14990799. PubMed CentralPMCID: PMC373525. See more on PubMed
    • Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF, Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology. 2004 Jan;145(1):24-35; discussion 21-3. doi: 10.1210/en.2003-0689. Epub 2003 Sep 11. PubMed PMID: 12970163. See more on PubMed
    • Hinkle RT, Donnelly E, Cody DB, Bauer MB, Isfort RJ. Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function. Endocrinology. 2003 Nov;144(11):4939-46. doi: 10.1210/en.2003-0271. Epub 2003 Jul 31. PubMed PMID: 12960070. See more on PubMed
    • Tanaka Y, Makino S, Noguchi T, Tamura K, Kaneda T, Hashimoto K. Effect of stress and adrenalectomy on urocortin II mRNA expression in the hypothalamic paraventricular nucleus of the rat. Neuroendocrinology. 2003 Jul;78(1):1-11. doi: 10.1159/000071700. PubMed PMID: 12869794. See more on PubMed
    • Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2843-8. doi: 10.1073/pnas.051626398. PubMed PMID: 11226328. PubMed CentralPMCID: PMC30227. See more on PubMed

  • References to Urocortin 3 Mouse/Rat ELISA

    • Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H. Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions. Peptides. 2005 Jul;26(7):1196-206. doi: 10.1016/j.peptides.2005.01.014. Epub 2005 Feb 19. PubMed PMID: 15949638. See more on PubMed
    • Fukuda T, Takahashi K, Suzuki T, Saruta M, Watanabe M, Nakata T, Sasano H. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders. J Clin Endocrinol Metab. 2005 Aug;90(8):4671-8. doi: 10.1210/jc.2005-0090. Epub 2005 May 24. PubMed PMID: 15914529. See more on PubMed
    • Chanalaris A, Lawrence KM, Stephanou A, Knight RD, Hsu SY, Hsueh AJ, Latchman DS. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. J Mol Cell Cardiol. 2003 Oct;35(10):1295-305. doi: 10.1016/s0022-2828(03)00244-x. PubMed PMID: 14519439. See more on PubMed
    • Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T, Sasano H, Shibahara S. Expression of urocortin III/stresscopin in human heart and kidney. J Clin Endocrinol Metab. 2004 Apr;89(4):1897-903. doi: 10.1210/jc.2003-031663. PubMed PMID: 15070962. See more on PubMed
    • Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF, Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology. 2004 Jan;145(1):24-35; discussion 21-3. doi: 10.1210/en.2003-0689. Epub 2003 Sep 11. PubMed PMID: 12970163. See more on PubMed
    • Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, Rivier J, Smith MS, Vale W. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology. 2003 Jul;144(7):3216-24. doi: 10.1210/en.2002-0087. PubMed PMID: 12810578. See more on PubMed
    • Li C, Vaughan J, Sawchenko PE, Vale WW. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci. 2002 Feb 1;22(3):991-1001. doi: 10.1523/JNEUROSCI.22-03-00991.2002. PubMed PMID: 11826127. PubMed CentralPMCID: PMC6758528. See more on PubMed
    • Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7570-5. doi: 10.1073/pnas.121165198. PubMed PMID: 11416224. PubMed CentralPMCID: PMC34709. See more on PubMed
    • Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med. 2001 May;7(5):605-11. doi: 10.1038/87936. PubMed PMID: 11329063. See more on PubMed
Subscribe to Our Newsletter! Discover News from
BioVendor R&D Subscribe Now
zavřít